Loading…
Loading…
Amplifon (OTCMKTS:AMFPF - Get Free Report) and Exagen (NASDAQ: XGN - Get Free Report) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, earnings, analyst recommendations, risk, profitability and valuation. Analyst Ratings This is a breakdown of current ratings and
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Amplifon S.p.A. (AMFPY) Q1 2026 Earnings Call Transcript
Franco-Italian eyewear giant EssilorLuxottica looked at investing in Italian hearing aid maker Amplifon in the past, CEO Francesco Milleri said on Tuesday.
Amplifon (OTCMKTS:AMFPF - Get Free Report) and First Choice Healthcare Solutions (OTCMKTS:FCHS - Get Free Report) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, dividends, profitability, valuation and risk. Analyst Recommendations This is a breakdown of
Amplifon S.p.A. (AMFPF) Q4 2025 Earnings Call Transcript
Amplifon (OTCMKTS:AMFPF - Get Free Report) and Sonic Healthcare (OTCMKTS:SKHHY - Get Free Report) are both mid-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, profitability, analyst recommendations, valuation, earnings, risk and dividends. Analyst Recommendations This is a summary of current
Amplifon (OTCMKTS:AMFPF - Get Free Report) and Eurofins Scient (OTCMKTS:ERFSF - Get Free Report) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, profitability, earnings and valuation. Volatility and Risk Amplifon has a beta of 0.44,
No recent filings indexed.